Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 2 , Pages 152-160, March 2006

The application of epigenetic modifiers on the treatment of prostate and bladder cancer

  • Zhengwang Zhang, M.D., Ph.D.

      Affiliations

    • Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9110, USA
    • ,
  • Jose Karam, M.D.

      Affiliations

    • Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9110, USA
    • ,
  • Eugene Frenkel, M.D.

      Affiliations

    • Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-9110, USA
    • ,
  • Arthur Sagalowsky, M.D.

      Affiliations

    • Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9110, USA
    • ,
  • Jer-Tsong Hsieh, Ph.D.

      Affiliations

    • Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9110, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-214-648-3988; fax: +1-214-648-8786

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by a United States Army grant (DAMD17-03-2-0033 and W81XWH-04-1-0222) and the National Institutes of Health (CA95730).

PII: S1078-1439(05)00265-6

doi:10.1016/j.urolonc.2005.11.004

Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 2 , Pages 152-160, March 2006

Article Tools